Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. David Hering$273.6M
Market Cap • 19/04/20242020
(há 4 anos)
2021
(3 years ago)
NASDAQ
Listagem
Waltham
Sede • Massachusetts86
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
IVVDSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.